JLK inhibitors: isocoumarin compounds as putative probes to selectively target the gamma-secretase pathway.
Checler F, Frédéric C, Alves da Costa C, Cristine Ada C, Ayral E, Erwan A, Andrau D, David A, Dumanchin C, Cécile D, Farzan M, Michael F, Hernandez JF, Jean-François H, Martinez J, Lefranc-Jullien S, Solveig LJ, Marambaud P, Philippe M, Pasini A, Andrea P, Petit A, Agnès P, Phiel C, Christopher P, Robert P, Philippe R, St George-Hyslop P, Peter SG, Wilk S, Sherwin W. JLK inhibitors: isocoumarin compounds as putative probes to selectively target the gamma-secretase pathway. Curr Alzheimer Res. 2005 Jul; 2(3):327-34.